China Kangtai Cactus Biotech Inc. (OTCBB:CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that it has engaged Kodiak Capital Group, LLC (hereinafter referred to as Kodiak) to conduct a $1.5 million equity raise to support its growth strategies.

China Kangtai CEO Jinjiang Wang said, "In our previous raise handled by Kodiak, proceeds were used as working capital for our cigarette plant in Macau. This has played an important part in our expansion strategy. We plan to use the proceeds from this new raise to enhance our financial liquidity and for other corporate matters that we believe will be beneficial to our shareholders."

About Kodiak Capital Group LLC ("Kodiak")

Kodiak is an institutional investor headquartered in New York City. Kodiak's experienced professionals manage a portfolio of investments in public and private entities. These investments are in a wide range of industries with an emphasis on life sciences, energy and technology. Kodiak's investments range from multiyear financial commitments to special situation financings offering companies certainty, flexibility and consistency. For more information, visit http://www.kodiak-capital.com.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

China Kangtai's online investor kit, including an investment profile, press releases, current price quotes, stock charts and more is available at http://www.hawkassociates.com/profile/ckgt.cfm. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Hawk Associates
Frank Hawkins or Amy Lin, 305-451-1888
kangtai@hawkassociates.com